# One Skin Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/one-skin-technologies

- Industry: Consumer Products
- Headquarters: San Francisco, US
- Website: www.oneskin.co
- Total disclosed funding: $27M
- Latest round: Series A (Aug 8, 2025)
- Investors on record: 7

## About

Based in California, US, and founded in 2016, One Skin Technologies operates as a skin longevity company. The company was founded by its CEO, Carolina Reis Oliveira, CTO, Alessandra Zonari, Mariana Boroni, and Juliana Carvalho. In August 2025, One Skin Technologies raised USD 20.36 million in series A funding from investor Prelude Growth Partners. The round is a part of a larger Series A funding round. The series A funding values One Skin Technologies at USD 142.31 million post-money. One Skin Technologies sells various products such as OS-01 Topical Supplement FACE, which is a skincare product that is meant to enhance skin health. The company’s product line includes OS-01 FACE Topical Supplement (50 ml), OS-01 BODY Topical Supplement (250 ml), and OS-01 Topical Supplement (15 ml). One Skin Technologies LLC generates revenue by charging USD 40–USD 120 for its products. The company will use the August 2025 funding to study how skin ages and make products that help keep skin healthy for a longer time.

## Funding rounds

- Series A, Aug 8, 2025, $20M — Prelude Growth Partners
- Series A, Sep 23, 2024, $7M — Unilever Ventures, SOSV, Plus Capital, Able Partners, Metaplanet Holdings, Selva Ventures
- Seed, Aug 24, 2022 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed, Series A
- Unilever Ventures (https://capitalatlas.ai/funds/unilever-ventures) — Series A
- Plus Capital (https://capitalatlas.ai/funds/plus-capital) — Series A
- Able Partners (https://capitalatlas.ai/funds/able-partners) — Series A
- Metaplanet Holdings (https://capitalatlas.ai/funds/metaplanet-holdings) — Series A
- Selva Ventures (https://capitalatlas.ai/funds/selva-ventures) — Series A
- Prelude Growth Partners — Series A
